Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1Endocrine 1

Conditions

Pituitary ACTH Hypersecretion 1Neoplasms 1Cushing Syndrome 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 2064Radiotherapy 1984Cisplatin 1851Carboplatin 1557Gemcitabine 1452Paclitaxel 1320Bevacizumab 1316pembrolizumab 1235Docetaxel 1225Oxaliplatin 1181Capecitabine 1173Fluorouracil 1081Dexamethasone 979Magnetic Resonance Spectroscopy 967Nivolumab 936Rituximab 928Drug Therapy 911Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 814Blood Specimen Collection 814Irinotecan 783Cytarabine 743fludarabine 723Leucovorin 682Surgical Procedures, Operative 638Lenalidomide 618Biopsy 592fludarabine phosphate 568

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Perceived Stress Scale × Clear all
NCT07326800 2026-04-16

MAEva-MCT

Institut de Cancérologie de Lorraine

Phase NA Recruiting
190 enrolled
Tumor-Agnostic

Neoplasms

NCT03364803 2025-10-23

Collecting Information About Treatment Results for Patients With Cushing's Syndrome

Memorial Sloan Kettering Cancer Center

Recruiting
300 enrolled
Endocrine

Cushing Syndrome, Pituitary ACTH Hypersecretion

NCT03781193 2018-12-20

MIND

Istituto Clinico Humanitas

Unknown
40 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡